All Articles
Treatment Decisions

Aortic Stenosis: TAVR vs. SAVR — How Age, Risk, and Anatomy Drive the Decision

Callistus Ditah, MDMarch 5, 2026

The TAVR Revolution — and Its Limits

Transcatheter aortic valve replacement (TAVR) has fundamentally changed the treatment of aortic stenosis. What began as a therapy for patients too sick for surgery has expanded to include intermediate and even low-risk patients. But the question of which patients benefit most from TAVR vs. surgical aortic valve replacement (SAVR) remains nuanced.

Current Guidelines: Risk-Stratified Decision Making

The 2020 ACC/AHA Valvular Heart Disease Guidelines recommend:

  • Low surgical risk (STS < 3%), age < 65 — SAVR preferred (longer durability data, better hemodynamics)
  • Low surgical risk, age 65-80 — Either TAVR or SAVR; shared decision-making
  • Intermediate risk (STS 3-8%) — Either TAVR or SAVR; Heart Team discussion
  • High risk (STS > 8%) — TAVR preferred
  • Prohibitive risk — TAVR only option

What the Numbers Don't Tell You

Risk scores provide a starting framework, but several factors influence the TAVR vs. SAVR decision beyond STS-PROM:

Anatomy

Bicuspid aortic valves, small annuli, horizontal aortas, and challenging vascular access can make TAVR technically difficult or impossible. Conversely, porcelain aorta or hostile chest (prior radiation, multiple sternotomies) may preclude SAVR.

Durability

SAVR valves (both mechanical and bioprosthetic) have 20+ years of durability data. TAVR valves have robust 5-year data and growing 10-year data, but lifetime management strategy matters more for younger patients. A 55-year-old will likely need a valve redo; the question is whether that redo is better planned as a surgical re-replacement or a valve-in-valve TAVR.

Concomitant Disease

If you need CABG, mitral repair, or aortic root surgery in addition to aortic valve replacement, SAVR allows these to be addressed in a single operation. TAVR treats the valve alone.

The Heart Team Imperative

The TAVR vs. SAVR decision is the textbook case for Heart Team review. It requires input from both an interventional cardiologist (who performs TAVR) and a cardiac surgeon (who performs SAVR) — ideally with neither having a financial incentive to recommend their own procedure.

This is exactly why independent second opinions matter. When both the surgeon and the cardiologist work for the same hospital, institutional incentives can subtly influence which option gets presented first.

Read our complete aortic stenosis guide or start your review.

aortic stenosisTAVRSAVRaortic valve replacementvalve disease
Related resources
What's My Risk? Second Opinion Quiz All Conditions Pricing
Stay informed.
Expert cardiac surgery insights from the WhiteGloveMD Heart Team, delivered to your inbox.
No spam. Unsubscribe anytime. HIPAA-compliant.

Continue reading

See all articles →
Treatment Options
TAVR vs SAVR: An Aortic Surgeon's Honest Guide to Choosing the Right Valve Replacement

Facing an aortic valve replacement decision? An aortic surgeon explains the real differences between TAVR and SAVR, who benefits most from each approach, and the questions you should be asking before you consent to either procedure.

Callistus Ditah, MD · May 26, 2026
Treatment Options
Structural Heart Interventions: A TAVR Procedure Overview for Patients and Families

A world-class interventional cardiologist explains what patients need to know about transcatheter aortic valve replacement (TAVR), including who qualifies, what to expect during the procedure, and how outcomes compare to traditional surgery. Practical guidance for patients and families navigating this decision.

Sandeep M. Patel, MD · May 26, 2026
Treatment Options
Tricuspid Valve Surgery: What Patients Need to Know About TR Repair Options and Treatment

Tricuspid regurgitation is often called the 'forgotten valve disease,' but left untreated it can lead to serious complications. Dr. Rahul Handa explains tricuspid valve surgery options, when treatment is necessary, and how to make informed decisions about TR repair.

Rahul R. Handa, MD · May 23, 2026